Compugen (Israel) Analysis

Compugen Stock Analysis Notes

About 28.0% of the company shares are held by institutions such as insurance companies. The company has price-to-book (P/B) ratio of 1.13. Some equities with similar Price to Book (P/B) outperform the market in the long run. Compugen recorded a loss per share of 0.4. The entity had not issued any dividends in recent years. Compugen Ltd., a clinical-stage therapeutic discovery and development company, engages in the research, development, and commercialization of therapeutic and product candidates in Israel, the United States, and Europe. Compugen Ltd. was incorporated in 1993 and is headquartered in Holon, Israel. COMPUGEN operates under Biotechnology classification in Israel and is traded on Tel Aviv Stock Exchange. It employs 68 people. For more info on Compugen please contact Anat CohenDayag at (972) 3 765 8555 or go to www.cgen.com.

Compugen Investment Alerts

Compugen Market Capitalization

The company currently falls under 'Small-Cap' category with a current market capitalization of 251.35 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Compugen's market, we take the total number of its shares issued and multiply it by Compugen's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.

Technical Drivers

As of the 6th of January, Compugen shows the Mean Deviation of 2.56, risk adjusted performance of 0.0246, and Downside Deviation of 3.34. Compugen technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices.

Compugen Price Movement Analysis

Compugen Outstanding Bonds

Compugen Predictive Daily Indicators

Compugen Forecast Models

Compugen's time-series forecasting models are one of many Compugen's stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Compugen's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

Compugen Debt to Cash Allocation

Compugen has accumulated 2.85 M in total debt with debt to equity ratio (D/E) of 0.03, which may suggest the company is not taking enough advantage from borrowing. Compugen has a current ratio of 9.41, suggesting that it is liquid and has the ability to pay its financial obligations in time and when they become due. Debt can assist Compugen until it has trouble settling it off, either with new capital or with free cash flow. So, Compugen's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Compugen sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Compugen to invest in growth at high rates of return. When we think about Compugen's use of debt, we should always consider it together with cash and equity.

Compugen Assets Financed by Debt

Typically, companies with high debt-to-asset ratios are said to be highly leveraged. The higher the ratio, the greater risk will be associated with the Compugen's operation. In addition, a high debt-to-assets ratio may indicate a low borrowing capacity of Compugen, which in turn will lower the firm's financial flexibility.

Compugen Corporate Bonds Issued

Stock analysis is the technique used by a trader or investor to examine and evaluate how Compugen prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Compugen shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Compugen. By using and applying Compugen Stock analysis, traders can create a robust methodology for identifying Compugen entry and exit points for their positions.

When running Compugen's price analysis, check to measure Compugen's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Compugen is operating at the current time. Most of Compugen's value examination focuses on studying past and present price action to predict the probability of Compugen's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Compugen's price. Additionally, you may evaluate how the addition of Compugen to your portfolios can decrease your overall portfolio volatility.